Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,286.20
-21.90 (-1.67%)
At close: Mar 19, 2026
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 181.23 billion as of March 19, 2026. Its market cap has increased by 7.68% in one year.
Market Cap
181.23B
Enterprise Value
208.49B
Revenue
30.65B
Ranking
n/a
PE Ratio
41.36
Stock Price
1,286.20
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 181.23B, an increase of 119.12%. That is a compound annual growth rate of 9.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 181.23B | -11.63% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 391.62B |
| Ajanta Pharma | 377.24B |
| Emcure Pharmaceuticals | 285.41B |
| Gland Pharma | 274.29B |
| Wockhardt | 193.15B |
| Piramal Pharma | 184.64B |
| NATCO Pharma | 171.57B |
| Alembic Pharmaceuticals | 131.70B |